Hemostemix Inc. (HMTXF)
Sector: Biotechnology
Industry: Biotechnology
Hemostemix Inc.
OTC:HMTXFHealthcare · Biotechnology
-31.71%$0.0239
CLOSED · Nov 16Prev close$0.0350-31.71%Close$0.0239
Mkt Cap$5.05M
EV-
Float168.41M
O/S211.44M
VOL79K sh
$ Vol$2K
RVOL1.85×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
MCap$5.05MFloat168.41MO/S211.44M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 0.0306 | 0.0306 | 0.0239 | 0.0239 | 79,000 |
| Nov 9, 2026 | 0.0350 | 0.0350 | 0.0350 | 0.0350 | 41,000 |
| Nov 6, 2026 | 0.0350 | 0.0361 | 0.0350 | 0.0350 | 121,100 |
| Nov 5, 2026 | 0.0360 | 0.0360 | 0.0357 | 0.0357 | 12,000 |
| Nov 3, 2026 | 0.0370 | 0.0370 | 0.0366 | 0.0366 | 32,999 |
| Oct 23, 2026 | 0.0409 | 0.0409 | 0.0409 | 0.0409 | 11,000 |
| Oct 21, 2026 | 0.0403 | 0.0403 | 0.0403 | 0.0403 | 2,000 |
| Oct 16, 2026 | 0.0408 | 0.0408 | 0.0401 | 0.0401 | 24,463 |
| Oct 13, 2026 | 0.0421 | 0.0421 | 0.0401 | 0.0401 | 10,500 |
| Oct 2, 2026 | 0.0435 | 0.0435 | 0.0435 | 0.0435 | 220 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases.
The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia.
The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.
Key Metrics
Market Cap$5.05M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 211.44M shares outstanding
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
Country
CA
IPO Date-
Shares Outstanding211.44M
Authorized Shares
Float168.41M
52-Week Range
$0.0239$0.0762
$0.0239(0th percentile)
Volume
Average Daily Volume42.73K
79.00K today vs 42.73K avg(+85%)
30d Avg
42.73K
60d Avg
30.49K
90d Avg
26.89K
Earnings
Dividend History
No dividend history available
Hemostemix Inc. (OTC: HMTXF) traded at $0.0239 on Nov 16, 2026, down 31.71% from the previous close of $0.0350. 52-week range: $0.0239 to $0.0762. The company is in the Healthcare sector (Biotechnology).